Conclusions
Enhanced knowledge of the significance of apoptosis in hepatic disease has justified much of the research reviewed in this chapter. Our improved knowledge of the process itself will lend itself to the development of new treatment approaches where therapeutic strategies can be aimed at more specific targets. New therapeutic routes are already being considered in hepatocyte culture and in hepatic disease, with some already in early development. Indeed, several small molecule caspase inhibitors have been undergoing trials for treatment of liver disease (Whelan et al., 2002) and no doubt some will be available soon. Of course the possible targets for such therapy are many in a process so complex.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adachi M. and Ishii H. (2002) Role of mitochondria in alcoholic liver injury. Free Radical Biology and Medicine 32(6), 487–491.
Albright C. D., Borgman C. and Craciunescu C. N. (2003) Activation of a caspase-dependent oxidative damage response mediates TGF1 apoptosis in rat hepatocytes. Experimental and Molecular Pathology
Antonsson B., Montessuit S., Lauper S., Eskes R. and Martinou J. C. (2000) Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochemistry Journal 345, 271–278
Bantel H., Ruck P., Gregor M. and Schulze-Osthoff K. (2001) Detection of elevated caspase activation and early apoptosis in liver disease. European Journal of Cell Biology 80, 230–239.
Blom W. M., de Bont H. J., Meirjerman I., Mulder G. J. and Nagelkerke J. F. (1999) Prevention of cycloheximide-induced apoptosis in hepatocytes by adenosine and by caspase inhibitor. Biochemical Pharmacology 58, 1891–1898.
Brenner C., Cadiou H., Vierra H., Zamzami N., Marzo I., Xie Z., Leber B., Andrews D., Duclohier H., Reed J. C. and Kroemer G. (2000) Bcl-2 and Bax regulate channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19, 329–336.
Budd R. C. (2001). Activation-induced cell death. Current Opinion in Immunology 13, 356–362.
Buttke T. M. and Sanstrom P. A. (1994) Oxidative stress as a mediator of apoptosis. Immunology Today 15, 7–10.
Cain K., Inayat-Hussain S. H., Couet C. and Cohen G. M. (1996) A cleavage-site-directed inhibitor of interleukin-1-convering enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes. Biochemical Journal 314, 27–32.
Cain K. and Freathy C. (2001) Liver toxicity and apoptosis: role of TGF-ß1, cytochrome c and the apoptosome. Toxicological Letters 120, 307–315.
Charlotte F., ĽHermine C., Martin N., Geleyn Y., Nollet M., Gaulard P. and Zafrani E.S. (1994) Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. American Journal of Pathology 144, 450–465.
Cleveland J. L. and Ihle J. N. (1995) Contenders in Fas/TNF death signalling. Cell 81, 479–482.
Enosawa S., Suzuki S., Kakefuda T. and Amenmiya H. (1996) Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines. Cell Transplantation 5(5), S39–S40.
Feldman G., Lamboley C., Moreau A. and Bringuier A. (1998) Fas-mediated apoptosis of hepatic cells. Biomed and Pharmacother 52, 378–385.
Frommel T.O., Yong S. and Zarling E. J. (1999) Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. American Journal of Gastroenterology 94(1), 178–182.
Galle P.R., Hoffman W. J. and Walczak H. (1995) Involvement of the CD95 ) APO-1/fas) receptor and ligand in liver damage. Journal of Experimental Medicine 82, 1223–1230.
Grossman M., Raper S. E., Kozarsky K., Stein E. A, Engelhardt J. F., Muller D., Lupien P. J. and Wilson J. M. (1994) Nature Genetics 6, 335–341.
Gupta S., Gorla G. R. and Irani A. N. (1999) Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies. Journal of Hepatology 30, 162–170.
Hammond A. H., Garle M. J., Sooriakumaran P. and Fry J. R. (2002) Modulation of hepatocyte thiol content by medium composition: implications for toxicity studies. Toxicology in Vitro 16, 259–265.
Hatano E., Bradham C. A., Stark A., Iimuro Y., Lemarsters J. J. and Brenner D. (2000) The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes. The Journal of Biological Chemistry 276(16), 11814–11823.
Herrera B., Alvarez A. M., Sanchez A., Fernandez M., Roncero C., Benito M. and Fabergat I. (2001). Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor ß in fetal hepatocytes. FASEB Journal 15, 741–751
Herrera B., Fernandez M., Benito M. and Fabergat I. (2002). cIAP-1, but not XIAP, is cleaved by caspases during the apoptosis induced TGB-in fetal rat hepatocytes. FEBS Letters 520, 93–96.
Hitchman N., Leaver M. and George S. (1995) Alternatives to whole animal testing: use of cDNA probes for studies of phase I and II enzyme induction in isolated plaice hepatocytes. Marine Environmental Research 39, 289–292.
Huang D. C., Hahne M., Schroeter M., Frei K., Fontana A., Villunger A. et la. (1999) Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL. Proceedings of the National Academy of Science USA 96, 14871–14876.
Ilyin G., Corlu A., Loyer P. and Guguen-Guillouzo C. (1997) Culture systems for hepatocytes for use in toxicology and differentiation studies. In Animal Cell Culture Techniques. (Martin Clynes. ed.). Springer, pp.371–392.
Ishii H., Kurose I and Kati S. (1997) Pathogenesis of alcoholic liver disease with particular emphasis on oxidative stress. Journal of Gastroenterology and Hepatology 12 (Suppl.), S272–S282.
Jaing S., Song M.J., Shin E. C., Lee M. O., Kim S. J. and Park J. H. (1999) Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fasindependent pathways. Hepatology 29, 101–110.
Kaplowitz N., Aw T. Y. and Ookhtens M. (1985) The regulation of hepatic glutathione. Annual Review of Pharmacology and Toxicology 25, 715–744.
Kerr J. F.R., Wyllie A. H. and Currie A. R. (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. British Journal of Cancer 26, 239–257.
Kiefer M. C. et al. (1995) Modulation of apoptosis by widely distributed Bcl-2 homologue Bak. Nature 374, 736–239.
Kim J. S., He L. and Lemasters J. L. (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochemical and Biophysical Research Communication 304, 463–470.
Krajewski S. et al., (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology 145, 1323–1336.
Kubo K., Matsuzaki Y. M., Okazaki M., Kato A., Kobayashi N. and Okita K. (1998) The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma. Liver 18, 117–123.
Kurose I’, Higuchi H., Kato S., Miura S., Watanabe N., Kamegaya Y., Tomit K., Takaishi M., Horie Y., Fukuda M., Mizukami K. and Ishii H. (1996) Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol. Gastroenterology 112, 131–159.
Lacronique V., Mignon A., Fabre M., Viollet B., Rouquet N., Molina T., Porteu A., Henrion A., Bouscary D., Varlet P., Joulin V. and Kahn A. (1996) Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Medicine 2 (1), 80–86.
Lamboley C., Bringuier A.F. and Feldman G. (2000) Apoptotic behaviour of hepatic and extra-hepatic tumour cell lines differs after Fas stimulation. Cell Mol Biology 46, 13–28.
Lamboley C., Bringuier A.F., Camus E., Lardeux B., Groyer A. and Feldman G. (2002) Overexpression of the mouse Fas gene in human Hep3B hepatoma cells overcomes their resistance to Fas-mediated apoptosis. Journal of Hepatology 36, 385–394.
Legallais C., David B. and Doré E. (2001) Bioartificial livers (BAL): current technological aspects and future developments. Journal of Membrane Science 181, 81–95.
Lemarsters J. L. (1999) Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. American Journal of Physiology 276, G1–G6.
MacEwan D. J. (2002) TNF receptor subtype signalling: Differences and cellular consequences. Cellular Signalling 14, 477–492.
Maeda S., Lin K. H., Inagaki H. and Saito T. (1996) Induction of apoptosis in primary cultures of rat hepatocytes by proteases inhibitors. Biochemistry and Molecular Biology International 39 (3), 447–453.
Mita E., Hayashi N., Lio S. (1994) Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochemical and Biophysical Research Communications 204, 468–474.
Miyoshi H., Yanagi K., Fukuda H., and Ohshima N. (1993) Long-term continuous culture of hepatocytes in a packed-bed reactor utilizing porous resin. Biotechnology and Bioengineering 43, 635–644.
Nakatani T., Tawaramoto M., Kennedy D.O., Kojma A. and Matsui-Yuasa I. (2000) Apoptosis induced by chelation of intracellular zinc is associated with depletion of cellular reduced glutathione level in rat hepatocytes. Chemico-Biological Interactions 125, 151–163.
Natori S., Rust C., Stadheim L. M., Srinivasan A., Burgart L. J. and Gores G. J. (2001) Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. Journal of Hepatology 34, 248–253.
Natoli G., Ianni A., Costanzo A., De Petrillo G., Ilari I., Chirillo P et al. (1995) Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11, 1157–1164.
Ni R., Tomita Y., Matsuda K., Ichihar A., Ishimura K., Ogasawar J. and Nagata S. (1994) Fas-mediated apoptosis in primary cultured mouse hepatocytes. Experimental Cell Research 215, 332–337.
Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T. and Nagata S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809.
Ohno Y., Miyajima A., Sunouchi M. (1998) Alternative methods for mechanistic studies in toxicology. Screening of hepatotoxicity of pesticides using freshly isolated and primary cultured hepatocytes and non-liver-derived cells, SIRC cells. Toxicology Letters 102–103, 569–573.
Patel T. and Gores G. J. (1995). Apoptosis and Hepatobiliary Disease. Hepatology 21(6), 1725–1741.
Rodriguez I., Matsuua K., Khatib J., Reed J. C., Nagata S. And Vassalli. (1996) A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. Journal of Experimental Medicine 183, 1031.
Rouquet N., Carlier K., Briand P., Wiels J. and Joulin V. (1996) Multiple pathways of Fasinduced apoptosis in primary culture of hepatocytes. Biochemical and Biophysical Research Communications 229, 27–35.
Sánchez A., Álvarez A. M., Benito M., Fabregat I. (1996) Apoptosis induced by transforming growth factor-β in foetal hepatocyte primary culture. The Journal of Biological Chemistry 271(13), 7416–7422.
Sánchez A., Álvarez A. M., Benito M., Fabregat I. (1997) Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor beta in fetal rat hepatocyte in primary culture. Hepatology 26, 935–943.
Sen C. K. and Packer L. (1996) Antioxidants and redox regulation of gene transcription. FASEB Journal 10, 709–720.
Schoemaker M. H., Ros J. E., Homan M., Trautwein C., Liston P., Poelstra K., van Goor H., Jansen P.L.M. and Moshage H. (2002) Cytokine regulation of pro-and anti-apoptotic genes in rat hepatocytes: NF-B-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. Journal of Hepatolgy 36, 742–750.
Shima Y., Nakao K., Nakashima T., Kawakami A., Nakata K., Hamasaki K., Kato Y., Eguchi K. and Ishii N. (1999) Hepatology 30, 1215–1222.
Simon A. R., Rai U., Fabburg B. L. and Cochran B. H. (1998) Activation of JAK-STAT pathway by reactive oxygen species. American Journal of Physiology 275, C1640–C1652.
Takeshi H., Kaplowitz N., Kammimura T., Tsukamoto H., Fernandez-Checa J. C. (1992) Hepatic mitochondrial GSH depletion and progression of experimental alcoholic liver disease in rats. Hepatology 16, 423–428.
Tirmenstein M. A., Nicholls-Grzemski F.A., Zhang J.-G and Fariss M. W. (2000) Glutathione depletion and he production of reactive oxygen species in isolated hepatocyte suspension. Chemico-Biological Interactions 127, 201–217.
Van Loo G., Lippens S., Hahne M., Mattijssens F., Declercq W., Saelens X. and Vandenabeele P. (2003) A bcl-2transgene expressed in hepatocytes does not protect mice from fulminant live destruction induced by Fas ligand. Cytokine 22, 62–70.
Wallach D. (1997) Placing death under control. Nature 388, 123–126.
Whelan J. (2002) Caspase inhibitors for liver disease. Drug Discovery Today 7, 444–445.
Woo M., Hakem A., Elia A. J., Hakem R., Duncan G. S., Patterson B. J. and Mak T. W. (1999) In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes. The Journal of Immunology 163, 4911–4916.
Zhang J-G, Tirmenstein M. A., Nicholls-Grzemski F. A. and Fariss M. W. (2001) Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and — independent cell death: protective role of antioxidants.
Ziol M., Tepper M., Lohez M., Arcangeli G., Ganne N., Christidis C., Trinchet J-C, Beaugrand M., Guillet J-G. and Guettier C. (2001) Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. Journal of Hepatology 34, 254–260.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Mukwena, N.T., Al-Rubeai, M. (2004). Apoptosis in Hepatocytes. In: Al-Rubeai, M., Fussenegger, M. (eds) Cell Engineering. Cell Engineering, vol 4. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2217-4_4
Download citation
DOI: https://doi.org/10.1007/1-4020-2217-4_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-2216-6
Online ISBN: 978-1-4020-2217-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)